DFB Pharma Report issue

For profit Phase 1 Phase 2
Founded: Fort Worth TX United States (1997)

Organization Overview

First Clinical Trial
2016
NCT03004339
First Marketed Drug
2017
docetaxel (taxotere)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DFB ONCOLOGY LTD | DFB Soria, LLC